1. Home
  2. RNA vs NHI Comparison

RNA vs NHI Comparison

Compare RNA & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • NHI
  • Stock Information
  • Founded
  • RNA 2012
  • NHI 1991
  • Country
  • RNA United States
  • NHI United States
  • Employees
  • RNA N/A
  • NHI N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • NHI Real Estate Investment Trusts
  • Sector
  • RNA Health Care
  • NHI Real Estate
  • Exchange
  • RNA Nasdaq
  • NHI Nasdaq
  • Market Cap
  • RNA 4.0B
  • NHI 3.7B
  • IPO Year
  • RNA 2020
  • NHI 1991
  • Fundamental
  • Price
  • RNA $69.83
  • NHI $76.97
  • Analyst Decision
  • RNA Buy
  • NHI Buy
  • Analyst Count
  • RNA 20
  • NHI 4
  • Target Price
  • RNA $69.26
  • NHI $82.75
  • AVG Volume (30 Days)
  • RNA 9.9M
  • NHI 202.5K
  • Earning Date
  • RNA 11-10-2025
  • NHI 11-06-2025
  • Dividend Yield
  • RNA N/A
  • NHI 4.76%
  • EPS Growth
  • RNA N/A
  • NHI 8.88
  • EPS
  • RNA N/A
  • NHI 3.17
  • Revenue
  • RNA $10,729,000.00
  • NHI $357,572,000.00
  • Revenue This Year
  • RNA N/A
  • NHI $4.68
  • Revenue Next Year
  • RNA $108.97
  • NHI $10.60
  • P/E Ratio
  • RNA N/A
  • NHI $24.38
  • Revenue Growth
  • RNA 1.23
  • NHI 8.40
  • 52 Week Low
  • RNA $21.51
  • NHI $65.13
  • 52 Week High
  • RNA $70.51
  • NHI $82.32
  • Technical
  • Relative Strength Index (RSI)
  • RNA 79.36
  • NHI 56.55
  • Support Level
  • RNA $69.67
  • NHI $74.87
  • Resistance Level
  • RNA $69.86
  • NHI $77.88
  • Average True Range (ATR)
  • RNA 0.80
  • NHI 1.79
  • MACD
  • RNA 0.52
  • NHI 0.30
  • Stochastic Oscillator
  • RNA 91.38
  • NHI 81.32

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About NHI National Health Investors Inc.

National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.

Share on Social Networks: